Login / Signup

KRAS G12 mutations as adverse prognostic factors in KMT2A-rearranged acute myeloid leukemia.

Shinju IyodaKenichi YoshidaKota ShojiNana ItoMiu TanakaYasuhito NannyaGenki YamatoShin-Ichi TsujimotoNorio ShibaYasuhide HayashiYusuke ShiozawaYuichi ShiraishiKenichi ChibaAi OkadaHiroko TanakaSatoru MiyanoYuhki KogaHiroaki GotoHiroshi MirotakiKiminori TeruiEtsuro ItoNobutaka KiyokawaMasanori YoshidaTakashi TagaAkio TawaJunko TakitaMomoko NishikoriSouichi AdachiSeishi OgawaHidemasa Matsuo
Published in: Leukemia (2024)
Keyphrases
  • prognostic factors
  • acute myeloid leukemia
  • allogeneic hematopoietic stem cell transplantation
  • wild type
  • adverse drug
  • emergency department
  • acute lymphoblastic leukemia